Antibiotic management

December 2001
Thorax;Dec2001 Supplement 4, Vol. 56, piv38
Academic Journal
Antimicrobial chemotherapy is essential to the management of community acquired pneumonia (CAP). While mild pneumonia may be self-limiting, the timely use of appropriate antibiotics abbreviates illness, reduces the risk of complications, and lowers mortality. The choice of antibiotic regimen may have consequences beyond the management of the individual patient. Overprescribing of macrolides and β-lactams, especially when administered parenterally in the management of hospitalised patients with CAP, possibly resulted from too loose an interpretation of "severe pneumonia."


Related Articles

  • Experience briefs. Stein, Gary E.; Havlichek, Daniel // Formulary;Dec95, Vol. 30 Issue 12, p817 

    Describes the development of a treatment protocol for hospitalized patients with community-acquired pneumonia. Five-day course of azithromycin plus a parenteral beta-lactam antibiotic; Effect on hospital stay; Effect on duration of outpatient antibiotic use.

  • β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. Nie, Wei; Li, Bing; Xiu, Qingyu // Journal of Antimicrobial Chemotherapy (JAC);Jun2014, Vol. 69 Issue 6, p1441 

    Objectives Several studies have compared the clinical effect of β-lactam/macrolide (BLM) dual therapy versus β-lactam (BL) monotherapy in community-acquired pneumonia (CAP) patients. However, the results remain controversial. Thus, we did this meta-analysis to determine which treatment was...

  • Treatment Options for Streptococcal Pharyngitis. Marcy, S. Michael // Clinical Pediatrics;May2007 Supplement, Vol. 46 Issue S4, p36S 

    Group A β-hemolytic streptococcus, the most common bacterial cause of pharyngitis, is susceptible to treatment with penicillins, macrolides, or cephalosporins. Current treatment guidelines recommend narrow-spectrum penicillins as first-choice therapy. Macrolides (erythromycin) and...

  • Current Challenges in Antimicrobial Chemotherapy: Focus on β-Lactamase Inhibition. Bebrone, Carine; Lassaux, Patricia; Vercheval, Lionel; Sohier, Jean-Sébastien; Jehaes, Adrien; Sauvage, Eric; Galleni, Moreno // Drugs;2010, Vol. 70 Issue 6, p651 

    The use of the three classical β-lactamase inhibitors (clavulanic acid, tazobactam and sulbactam) in combination with b-lactam antibacterials is currently the most successful strategy to combat β-lactamase-mediated resistance. However, these inhibitors are efficient in inactivating only...

  • pivmecillinam. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p611 

    An encyclopedia entry for "pivmecillinam" is presented. It refers to a type of penicillin drug.

  • Clinical Efficacy of Newer Agents in Short-Duration Therapy for Community-Acquired Pneumonia. File Jr., Thomas M. // Clinical Infectious Diseases;9/1/2004 Supplement, Vol. 39, pS159 

    Streptococcus pneumoniae, the most important respiratory tract pathogen implicated in community-acquired pneumonia (CAP), is becoming increasingly resistant in vitro to the β-lactams and macrolides, and fluoroquinolone resistance has been detected. A growing body of evidence suggests that...

  • Commentary. Morris, Andrew M. // Evidence Based Medicine;Jun2006, Vol. 11 Issue 3, p74 

    The article comments on the medical research entitled "Review: Empirical Atypical Coverage Does Not Reduce Mortality in Hospitalized Patients With Community Acquired Pneumonia." The author stresses that the review for this study does not suggest that any benefit is conferred by macrolides and...

  • Experimental-Computational Evaluation of Antimicrobial Activity of Some β-Lactams: Advantages and limitations. Jarrahpour, Aliasghar; El-Mounsi, Ibrahim; Hadda, Taibi Ben; Jawarkar, Rahul; Masand, Vijay // Journal of Computational Methods in Molecular Design;2011, Vol. 1 Issue 4, p28 

    Experimental-computational evaluation of in-vitro antimicrobial activity of mono and bicyclic β- lactams is described. The compounds prepared were tested against various Gram-positive and Gram-negative bacterial species such as Escherichia coli, Stapylococcus citrus, Klebsiella pneumonae and...

  • Review: antibiotics active against atypical pathogens do not improve community acquired pneumonia more than β lactam antibiotics. Mills, G. D.; Oehley, M. R.; Arroll, B. // Evidence Based Medicine;Aug2005, Vol. 10 Issue 4, p115 

    The article presents a study on the role of antibiotics that are active against atypical pathogens and lactam antibiotics in improving community acquired pneumonia. 18 RCTs met the selection criteria. The trials evaluated 9 different fluoroquinolones, 2 macrolides and 1 ketolide. No RCT showed a...


Read the Article


Sign out of this library

Other Topics